| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4164466 | The Journal of Pediatrics | 2016 | 6 Pages |
Abstract
Under routine use, the RV1 and RV5 series were both effective against moderate-to-severe rotavirus disease during a G12P[8] season, and both vaccines demonstrated sustained protection beyond the first 2Â years of life.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
Lilly Cheng MD, MS, Trisha Chan MPH, Shabnam MD, MPH, Elham MS, Philip MD, Robert C. PhD, Michael D. PhD, Umesh D. MBBS, MPH, Margaret M. MD,